As public health insurance payouts for medical cannabis in Germany stagnate, entrepreneurs are focusing instead on the private health-care sector, where medical consultations and marijuana is paid for directly by patients. Although Germany is often seen as an attractive market because statutory health insurers are expected to cover the cost of medical marijuana, opportunities in the private market maybe even more attractive for some companies. Stefan Fritsch, the founder of Grünhorn, a pharmacy in Leipzig that specializes in medical cannabis, believes the private market is growing strong. He told Marijuana Business Daily that Grünhorn’s sales of medical cannabis to patients using private prescriptions had experienced double-digit monthly growth through all of 2020. Algea Care, a German telemedicine company founded in June 2020, started prescribing cannabis to patients in September. By December, it had more than 500 active patients receiving cannabis prescriptions, co-CEOs Anna Kouparanis and Julian Wichmann told MJBizDaily.

Marijuana Business Daily, 01/12/2021 09:39:00

Open article: